← Back to Search
The Role Of Endocannabinoid Transmission In Cocaine Addiction
Published 2005 · Medicine, Psychology
Download PDFAnalyze on Scholarcy
Research is beginning to outline a role for the endocannabinoid system in cocaine addiction. Human and animal studies indicate that exogenous cannabinoids modulate the acute rewarding effects of cocaine. These studies, however, cannot directly investigate the necessity of endocannabinoid transmission in cocaine addiction. Studies that do offer a direct assessment show that neither pharmacological antagonism nor deletion of the CB1 receptor alters the acute rewarding effects of cocaine. In contrast, CB1 receptors appear to be involved in the association of cocaine reward with environmental cues and reinstatement of cocaine self-administration. Together, these results point to CB1 receptor antagonists as potential anti-craving compounds in the treatment of cocaine addiction. Given the limitations of human population studies, animal research may be useful in discerning causal inferences between cannabis and cocaine use. While animal research suggests cannabis use may precipitate cocaine relapse, cross-sensitization between cannabinoids and cocaine has not been demonstrated and CB1 receptors do not mediate behavioral sensitization to cocaine. The effect of acute or chronic cocaine on endocannabinoid transmission in reward-related areas of the brain is relatively under-researched. Acute cocaine administration increases anandamide levels in the striatum, an effect that is mediated by dopamine D2-like receptors. Conversely, chronic cocaine exposure has no effect on anandamide, but decreases 2-arachidonylglycerol levels in the limbic forebrain. This review highlights research indicating that the endocannabinoid system may subserve certain aspects of cocaine addiction and suggests avenues for future investigation.
This paper references
Glutamate systems in cocaine addiction.
P. Kalivas (2004)
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
G. Gerdeman (2002)
A missense mutation in human fatty acid amide hydrolase associated with problem drug use
J. Sipe (2002)
Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis.
L. Hernández (1988)
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
V. Marzo (1998)
Cannabinoid Transmission and Reward-Related Events
E. Gardner (1998)
The endocannabinoid nervous system: unique opportunities for therapeutic intervention.
A. Porter (2001)
Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans.
R. W. Foltin (1993)
Exogenous and Endogenous Cannabinoids Control Synaptic Transmission in Mice Nucleus Accumbens
D. Robbe (2003)
A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior
J. Cornish (1999)
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
R. Wilson (2001)
Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain
H. Hermann (2002)
Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine
M. Thomas (2001)
SHORT COMMUNICATION Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids
B. Szabó (2002)
Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C‐terminal tail of CB1
M. Egertová (2000)
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
K. Tsou (1998)
Reassessing the marijuana gateway effect.
A. Morral (2002)
Neurobiology of Relapse to Heroin and Cocaine Seeking: A Review
U. Shalev (2002)
d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.
M. Raiteri (1975)
The endogenous cannabinoid system controls extinction of aversive memories
G. Marsicano (2002)
Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking.
J. Stewart (2000)
Functional role of high-affinity anandamide transport, as revealed by selective inhibition.
M. Beltramo (1997)
Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.
M. A. Gorriti (1999)
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
G. Tanda (1997)
Pharmacological treatments for heroin and cocaine addiction
W. Brink (2003)
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
A. Howlett (2002)
CB1 cannabinoid receptor agonist WIN 55, 212-2 decreases intravenous cocaine self-administration in rats
L. Fattore (1999)
Brain circuitry and the reinstatement of cocaine-seeking behavior
Peter W. Kalivas (2003)
The effects of levonantradol on rewarding brain stimulation thresholds in the rat
L. Kucharski (1983)
Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses.
D. Bonhaus (1998)
Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors
S. Nicola (1996)
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
A. Giuffrida (1999)
Drug-induced reinstatement of extinguished self-administration behavior in monkeys
G. Gerber (1975)
Acute injection of drugs with low addictive potential (delta(9)-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine).
M. Erdtmann-Vourliotis (1999)
Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests
J. Crawley (1999)
The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain
J. Arnold (2001)
Mediation of Amphetamine-Induced Long-Term Depression of Synaptic Transmission by CB1 Cannabinoid Receptors in the Rat Amygdala
Y. Huang (2003)
Carrier‐mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2‐arachidonylglycerol
M. Beltramo (2000)
Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat.
F. Ferrari (1999)
Monoamine transporters and psychostimulant drugs.
R. Rothman (2003)
Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission
I. Katona (2001)
Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis
J. Chen (2005)
Conditioned place preference as a measure of drug reward.
G. Carr (1989)
Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.
T. Bisogno (1997)
The reinstatement model and relapse prevention: a clinical perspective
D. H. Epstein (2003)
Vulnerability to drug abuse
M. Glantz (1992)
Drug addiction: bad habits add up
T. Robbins (1999)
Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens
D. Robbe (2001)
Stereochemical requirements for cannabimimetic activity.
R. Mechoulam (1987)
The dopamine hypothesis of the reinforcing properties of cocaine
M. Kuhar (1991)
WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation
S. Vlachou (2003)
Addictive potential of cannabinoids: the underlying neurobiology.
E. Gardner (2002)
Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats
E. Carboni (1989)
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
N. Hájos (2001)
Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
P. Mailleux (1992)
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
V. Marzo (1994)
A cannabinoid mechanism in relapse to cocaine seeking
T. Vries (2001)
Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice.
M. S. Mascia (1999)
A Critical Interaction between Dopamine D2 Receptors and Endocannabinoids Mediates the Effects of Cocaine on Striatal GABAergic Transmission
D. Centonze (2004)
Marijuana's interaction with brain reward systems: Update 1991
E. Gardner (1991)
From beer to crack: developmental patterns of drug involvement.
D. Kandel (1993)
Escalation of drug use in early-onset cannabis users vs co-twin controls.
M. Lynskey (2003)
Absence of Δ-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice
Andreas Zimmer (2001)
Cannabinoid Addiction: Behavioral Models and Neural Correlates
R. Maldonado (2002)
Neurobiological mechanisms in the transition from drug use to drug dependence
G. Koob (2004)
Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: dependence upon dopamine uptake inhibition.
R. Heikkila (1979)
Enantiomeric cannabinoids: stereospecificity of psychotropic activity
R. Mechoulam (2005)
Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs
P. Vézina (2004)
Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine.
J. Arnold (1998)
Limbic and Motor Circuitry Underlying Footshock-Induced Reinstatement of Cocaine-Seeking Behavior
K. McFarland (2004)
Evidence for carrier-mediated efflux of dopamine from corpus striatum.
N. Y. Liang (1982)
Reinstatement of cocaine-reinforced responding in the rat
H. Wit (2004)
Does marijuana use cause the use of other drugs?
D. Kandel (2003)
Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors
R. Seifert (2002)
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
S. Jones (1998)
Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers
M. E. Reith (1997)
Cocaine treatment outcome: cocaine use following inpatient, outpatient, and no treatment.
R. Rawson (1986)
The Neuropharmacological basis of reward
J. Liebman (1989)
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse
G. Cossu (2001)
Effect of low doses of Δ9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats
L. Parker (2004)
Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study
Y. Hurd (1989)
Astrocytes in Culture Produce Anandamide and Other Acylethanolamides*
Lisa Walter (2002)
A second endogenous cannabinoid that modulates long-term potentiation
N. Stella (1997)
Drug abuse potential evaluation in animals.
R. L. Balster (1991)
Role of endogenous cannabinoids in synaptic signaling.
T. Freund (2003)
Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population.
D. Kandel (1997)
Drug Addiction: The Yin and Yang of Hedonic Homeostasis
G. Koob (1996)
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine
Sara González (2002)
Cannabinoid receptor gene (CNR1): association with IV drug use
D. Comings (1997)
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders
M. Stelt (2003)
Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in rats
S. Schenk (1999)
Progression to regular marijuana involvement: Phenomenology and risk factors for near-daily use.
D. Kandel (1992)
Cocaine self-administration in dopamine-transporter knockout mice
B. Rocha (1998)
Pharmacological treatment of cocaine dependence: a systematic review.
M. D. de Lima (2002)
It could be habit forming: drugs of abuse and striatal synaptic plasticity
G. Gerdeman (2003)
The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2.
N. Darmani (2001)
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
D. Robbe (2002)
A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1
M. Bouaboula (1997)
Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Augments cAMP Accumulation in Striatal Neurons: Evidence for a Gs Linkage to the CB1 Receptor
M. Glass (1997)
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions
M. Pistis (2004)
Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats.
J. Arnold (2001)
Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens.
O. Manzoni (2001)
Cocaine and Amphetamine Increase Extracellular Dopamine in the Nucleus Accumbens of Mice Lacking the Dopamine Transporter Gene
E. Carboni (2001)
Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration.
R. Esposito (1977)
Preclinical research on cocaine self-administration: environmental determinants and their interaction with pharmacological treatment
M. Lesage (1999)
Behavioural sensitization after repeated exposure to Δ9-tetrahydrocannabinol and cross-sensitization with morphine
C. Cadoni (2001)
Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis
H. Pettit (1989)
Marihuana smoking increases plasma cocaine levels and subjective reports of euphoria in male volunteers
S. Lukas (1994)
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats
L. Fattore (2001)
Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats
R. Mansbach (2005)
Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior.
M. E. Reith (1986)
Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys
G. Tanda (2000)
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice
M. C. Martellotta (1998)
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data
G. Tanda (2003)
D2 Dopamine Receptors Modulate Gα-Subunit Coupling of the CB1 Cannabinoid Receptor
A. Jarrahian (2004)
Evaluating alternative cannabis regimes.
R. MacCoun (2001)
Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.
A. Hoffman (2001)
Dissociation of Primary and Secondary Reward-Relevant Limbic Nuclei in an Animal Model of Relapse
Jeffrey W Grimm (2000)
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.
C. Ledent (1999)
Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats
F. Chaperon (1998)
Addictive drugs and brain stimulation reward.
R. Wise (1996)
The neural basis of drug craving: An incentive-sensitization theory of addiction
T. Robinson (1993)
Behavioral effects of cannabinoid agents in animals.
F. Chaperon (1999)
Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice
M. Martín (2000)
Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction
J. Cornish (2000)
Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
R. Heikkila (1975)
The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors.
T. Bisogno (2001)
Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels.
S. González (2002)
Chronic treatment with Δ9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction
S. Lamarque (2001)
Anandamide Amidohydrolase Activity in Rat Brain Microsomes
F. Desarnaud (1995)
This paper is referenced by
Phasic Dopamine Release Evoked by Abused Substances Requires Cannabinoid Receptor Activation
J. Cheer (2007)
Role of the Endocannabinoid System in Extinction of Learned Behaviours Motivated by Opioid-Induced Reward and Aversion in Rats
L. A. Manwell (2013)
INTRINSIC MEMBRANE ADAPTATIONS TO COCAINE EXPOSURE AND SLEEP DEPRIVATION
Bradley D Winters (2012)
Development of new neurobiological strategies to treat patients with cocaine dependence
C. Crunelle (2008)
Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future
G. Panagis (2014)
Augmented Acquisition of Cocaine Self-Administration and Altered Brain Glucose Metabolism in Adult Female but not Male Rats Exposed to a Cannabinoid Agonist during Adolescence
A. Higuera-Matas (2008)
Drugs in pregnancy: the effects on mother and her progeny.
R. Šlamberová (2012)
Gene Set Enrichment Analysis (GSEA) of Upregulated Genes in Cocaine Addiction Reveals miRNAs as Potential Therapeutic Agents
Ishtiaque Ahammad (2018)
Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice
L. Yu (2008)
The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review
C. Crunelle (2010)
Clearing the Smokescreen: The Current Evidence on Cannabis Use
Elizabeth C. Temple (2015)
Cannabinoid receptor 1 gene association with nicotine dependence.
X. Chen (2008)
Subchronic Cannabinoid Agonist (WIN 55,212-2) Treatment during Cocaine Abstinence Alters Subsequent Cocaine Seeking Behavior
G. González-Cuevas (2007)
Interaction Between Orexins and the Mesolimbic System for Overriding Satiety
M. Hirasawa (2007)
Chronic cocaine treatment alters dendritic arborization in the adult motor cortex through a CB1 cannabinoid receptor–dependent mechanism
I. Ballesteros-Yañez (2007)
Pharmacological treatments for cocaine dependence: is there something new?
L. Karila (2011)
New horizons for therapeutics in drug and alcohol abuse.
B. Jupp (2010)
Long-lasting increase in [3H]CP55,940 binding to CB1 receptors following cocaine self-administration and its withdrawal in rats
Przemysław Adamczyk (2012)
An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives
L. Fattore (2007)
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
T. Sugiura (2006)
Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.
Z. Xi (2008)
Cannabinoids: Neurochemistry and neurobiology
A. I. Golovko (2011)
Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans
L. Zuo (2009)
Cocaine‐induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice
M. Mereu (2015)
The role of the endocannabinoid system in attention and nicotine addiction
W. V. Klinken (2011)
Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training
B. Bystrowska (2014)
Cannabinoid receptor 1-expressing neurons in the nucleus accumbens
Bradley D Winters (2012)
Cannabinoid CB1 Receptor Antagonists Attenuate Cocaine's Rewarding Effects: Experiments with Self-Administration and Brain-Stimulation Reward in Rats
Z. Xi (2008)
Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors.
G. Tanda (2009)
Targeted modulators of the endogenous cannabinoid system: Future medications to treat addiction disorders and obesity
D. Janero (2007)
Neuroinflammation as a possible link between cannabinoids and addiction.
L. C. M. Rodrigues (2014)
Estudio psicofarmacológico de la modulación del sistema cannabinoide y su implicación neurocomportamental en la adicción a cocaína
G. G. Cuevas (2011)See more